SCV
BBNX

Sands Capital Ventures’s Beta Bionics BBNX Stock Holding History

Sands Capital Ventures’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$58.1M Hold
3,708,043
– – 9.47% 4
2026
Q1 		$37.2M Buy
3,708,043
+137,930
+4% +$2.04M 8.82% 4
2025
Q4 		$109M Hold
3,570,113
– – 20.98% 3
2025
Q3 		$70.9M Hold
3,570,113
– – 15.54% 3
2025
Q2 		$52M Buy
3,570,113
+466,331
+15% +$6.6M 10.24% 4
2025
Q1 		$38M Buy
+3,103,782
New +$57.9M 9.29% 4

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return

Sands Capital Ventures's BBNX Position: Q2 2026 in Review

Sands Capital Ventures held its Beta Bionics (BBNX) position steady in Q2 2026 at 3,708,043 shares worth $58.1M. The position accounts for 9.47% of the portfolio, ranked #4.

Sands Capital Ventures first reported a position in BBNX in Q1 2025 and has held it in 6 quarters since. The position peaked at $109M in Q4 2025. 123 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • Sands Capital Ventures held 3,708,043 shares of Beta Bionics worth $58.1M as of Q2 2026.
  • Sands Capital Ventures left its Beta Bionics share count unchanged in Q2 2026.
  • Beta Bionics made up 9.47% of Sands Capital Ventures's portfolio in Q2 2026, its #4 holding.
  • Sands Capital Ventures first reported a position in Beta Bionics in Q1 2025 and has held it in 6 quarters since.
  • Sands Capital Ventures's Beta Bionics position peaked at $109M in Q4 2025.
  • 123 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on Sands Capital Ventures's 13F filing for Q2 2026, filed 13 Aug 2026.